| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 44.6× | −1.7× | |
| Price / Book | 3.1× | 2.0× | |
| Price / Sales | 6.6× | 3.9× | |
| Price / Free cash flow | 30.6× | −1.6× | |
| EV / EBITDA | 25.2× | −1.2× | |
| Earnings yield | 2.2% | −14.6% | |
| Free cash flow yield | 3.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,243.59 | −1.07% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.66 | −0.74% | $611.29B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.10 | −0.81% | $500.27B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.89 | +1.36% | $365.22B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.62 | −1.60% | $354.34B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.16 | −0.31% | $277.78B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.04 | −0.83% | $254.41B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $678.77 | −1.63% | $250.97B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $425.05 | −1.72% | $229.8B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.09 | −1.99% | $189.82B | 22.8× | 37.5% | +32.0% |
